Nektar Therapeutics (NKTR)
76.99
+1.28
(+1.69%)
USD |
NASDAQ |
Apr 02, 16:00
77.30
+0.31
(+0.40%)
After-Hours: 20:00
Nektar Therapeutics Total Assets (Quarterly) : 280.41M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Boston Scientific Corp. | 43.67B |
| Eli Lilly & Co. | 112.48B |
| Regeneron Pharmaceuticals, Inc. | 40.56B |
| Rigel Pharmaceuticals, Inc. | 560.62M |
| Esperion Therapeutics, Inc. | 883.74M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 190.57M |
| Shareholders Equity (Quarterly) | 89.83M |
| Debt to Equity Ratio | 1.658 |
| Current Ratio | 4.974 |
| Net Debt Paydown Yield | 1.56% |